Regina Barragan: Meet the Experts of VIRO 2025

The Global Voices in Renal Oncology (VIRO) Virtual Congress, organized by OncoDaily, will be held on September 11–12, 2025. Chaired by Dr. Rana R. McKay with co-chair Dr. Yüksel Ürün, this year’s program will feature around 50 leading experts in renal oncology from across the globe, sharing cutting-edge updates and future perspectives.

• The congress is free to attend.
• Register via the link.

Co-Chair of VIRO

Images

Name

Rana McKay Professor of Medicine and Urology at UC San Diego Health Co-leader of the GU Oncology Program at Moores Cancer Center As Co-Chair of VIRO, Dr. Rana McKay (University of California, San Diego) opened the congress with her talk on  “Future Directions: Emerging Agents and Combinations.” She emphasized the momentum in renal cell carcinoma (RCC) research, highlighting how novel immunotherapies, targeted drugs, and rational combination strategies are reshaping patient care. Dr. McKay underscored the importance of personalized, biomarker-driven approaches and global collaboration, aiming to optimize survival and quality of life worldwide.

Spotlight on Regina Barragan

Dr. Regina Barragan is a Postdoctoral Fellow at the Genitourinary Clinic within the Medical Oncology and Medical Therapeutics departments at City of Hope, Duarte, CA.

At the Global Voices in Renal Oncology (VIRO) Virtual Congress 2025, Dr. Barragan will present on “The Current State of Renal Oncology in Mexico.” Her presentation will cover:

• Epidemiology and clinical management of renal cancer in Mexico, highlighting regional challenges and healthcare disparities.
• Advances in first- and second-line treatments for metastatic renal cell carcinoma based on recent clinical trial updates.
• Efforts to integrate novel therapies and optimize patient outcomes within Mexican oncology practice.
• Ongoing research and collaborations aimed at improving access and treatment equity in renal oncology.

Dr. Barragan combines clinical expertise with active research involvement, emphasizing personalized care and the importance of equitable oncology advancements for Mexican patients.

Global Voices in Renal Oncology (VIRO) 2025